E2C(R2) Periodic Benefit-Risk Evaluation Report – Questions and Answers
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 19, 2016
December 29, 2022
9735c0c5-468e-4e9b-a4c9-a7bad1eb9d94
Related Documents
Q7 Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients Questions and Answers Guidance for Industry
Guidance DocumentApril 20, 2018Center for Drug Evaluation and Research
S9 Nonclinical Evaluation for Anticancer Pharmaceuticals--Questions and Answers
Guidance DocumentMarch 8, 2010Center for Drug Evaluation and Research
E2C(R2) Periodic Benefit-Risk Evaluation Report (PBRER)
Guidance DocumentJuly 18, 2016Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox